跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Havrix 720 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Havrix 720
Approved
STANDARD
Havrix 720
GlaxoSmithKline Biologicals SA
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
c6ee03ca472c62d5
Company
GlaxoSmithKline Biologicals SA
Type
Standard
Approval Details
Approval Id
c6ee03ca472c62d5
Drug Approval Philippines Name
Havrix 720
Product Name
Havrix 720
Registration Number
BR-1303
Brand Name
Havrix 720
Generic Name
Hepatitis A (Inactivated) Vaccine (Adsorbed)
Dosage Form
Suspension for Injection (IM)
Dosage Strength
720 ELISA units/0.5 mL
Manufacturer
GlaxoSmithKline Biologicals SA
Importer
GlaxoSmithKline Philippines, Inc.
Company Detail Path
/organization/glaxosmithkline-biologicals-sa
Issuance Date
28 June 2024
Expiry Date
28 June 2029
Pharmacologic Category
Vaccine
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
c6ee03ca472c62d5
Type
Standard
Back to Philippines FDA Approvals